SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-001514
Filing Date
2024-01-05
Accepted
2024-01-05 16:05:53
Documents
15
Period of Report
2024-01-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191250-8k_augmedix.htm   iXBRL 8-K 36118
2 PRESS RELEASE DATED JANUARY 5, 2024 ANNOUNCING PRELIMINARY FOURTH QUARTER 2023 F ea191250ex99-1_augmedix.htm EX-99.1 22035
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2659
4 GRAPHIC ex99-1_002.jpg GRAPHIC 1945
  Complete submission text file 0001213900-24-001514.txt   246395

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE augx-20240105.xsd EX-101.SCH 3015
6 XBRL LABEL FILE augx-20240105_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE augx-20240105_pre.xml EX-101.PRE 22359
9 EXTRACTED XBRL INSTANCE DOCUMENT ea191250-8k_augmedix_htm.xml XML 3414
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

IRS No.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40890 | Film No.: 24516256
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)